GlassScriptPhysician profile
Garrison Lawrence Whitaker
NPI 1467654509
$8,644.30
in general payments reported to CMS, 2019-2025
12 companies · $1,141 in 2025
The $1,141 reported for 2025 was more than what 75% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,962 · 2021: $275 · 2022: $166 · 2023: $100 · 2025: $1,141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $828 · Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $827.90 |
| Food and Beverage | $413.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $6,075.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $769.23 | 2019 | |
| Arthrex, INC. | $592.06 | 2025 | |
| Impactortho, INC. | $529.26 | 2025 | |
| Acumed LLC | $237.61 | 2021 | |
| Skeletal Dynamics INC | $117.65 | 2019 | |
| Depuy Synthes Sales INC. | $113.06 | 2022 | |
| Alafair Biosciences, INC. | $100.42 | 2023 | Versawrap |
| Smith+Nephew, INC. | $56.47 | 2021-2022 | |
| Bioventus LLC | $20.10 | 2025 | Durolane |
| Integra Lifesciences Corporation | $19.50 | 2022 | |
| Aroa Biosurgery Incorporated | $13.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrison Whitaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.